Amrize Ltd (AMRZ) fair value: what the stock is really worth
As of Nov 5, 2026: fair value (intrinsic value) of Amrize Ltd stock $35.08, price $42.65, that is 17.7% below the price, quality 55 out of 100. Rating: overvalued. Calculated from audited financials with 23 of our 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 5, 2026.
How to read this chart
16‑month range $36.09 – $65.06 · fair‑value band $24.02 – $46.04 · the $42.65 price screens above the $35.08 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 5, 2026.
Follow Amrize in your weekly email
Every Wednesday you see whether Amrize is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Amrize AG engages in the provision of various building solutions for infrastructure, commercial, and residential construction markets in North America. It operates through two segments, Building Materials and Building Envelope.
Show moreShow less
The Building Materials segment offers cement and aggregates, as well as ready-mix concrete, asphalt, and other construction materials.
The Building Envelope segment provides advanced roofing and wall systems, including single-ply membranes, insulation, shingles, sheathing, waterproofing, and protective coatings; and adhesives, tapes, and sealants.
The company was formerly known as Holcim North America Finance Ltd and changed its name to Amrize AG in December 2013. Amrize AG was incorporated in 2023 and is based in Zug, Switzerland.
Stock analysis
Amrize Ltd (AMRZ) currently trades at $42.65, while our model-based Fair Value estimate is $35.08, 18% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $34.93 per share, and 2 of the 23 models we run sit above the $42.65 price.
Bear case: the Economic Profit group reads lowest at $22.51, and 21 of the 23 models stay below the price. Data coverage for this calculation is medium.
Scenario range: $24.02 (bear) to $46.04 (bull), the price of $42.65 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 55/100 (solid quality), in the Basic Materials sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Amrize Ltd reported revenue of $11.8B in FY2025 versus $8.1B in FY2021, a compound +9.8%/yr. Reported net income was $1.2B in FY2025, compounding +9.0%/yr from FY2021.
Key figures
Market cap $23.6B Large · P/E ratio 19.1 · P/S ratio 1.93 · EPS (TTM) $2.23 · Net margin 10.2% · Return on equity 9.7% · Return on assets (EBIT) 8.4% · Operating margin 21.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 53 out of 100 (low confidence).
What moves the price
The share trades about 34% below its 52-week high and 18% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −21% fair-value upside, at −18%, AMRZ screens cheaper than that median.
Fair Value models
Bear$24.02Fair Value $35.08Bull$46.04
Price $42.65 · Downside -17.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($1.89 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
In the last 6 months, 11 officers or directors bought shares worth $5.4M, most recently on Sep 2, 2026. Buying cluster
BuyJan Philipp JenischChairman & CEO, Director4× since Mar 6, 2026: 137,418 shares, avg. $51.69$7.1MSep 2, 2026
BuyDwight Audley Konrad GibsonDirector5.47 shares at $44.58$244Aug 27, 2026
BuyJacques Wolf SancheDirector4,150 shares at $45.02$186,833Aug 26, 2026
BuyDenise R SingletonChief Legal Officer & Corp Sec3,500 shares at $44.12$154,420Aug 25, 2026
BuyNollaig ForrestChief Mktg & Corp Affairs Off2× since May 22, 2026: 3,500 shares, avg. $47.64$166,725Aug 25, 2026
BuySamuel Jonas PolettiChief Strategy & M&A Officer2,510 shares at $46.92$117,769Aug 17, 2026
BuyBaris OranChief Financial Officer6,000 shares at $47.26$283,530Aug 12, 2026
BuyStephen S ClarkChief People Officer2× since May 5, 2026: 5,262 shares, avg. $47.31$248,964Aug 11, 2026
BuyRoald BrouwerChief Technology Officer4× since Mar 11, 2026: 8,000 shares, avg. $53.78$430,220Aug 11, 2026
BuyMario GrossChief Supply Chain Officer3× since Mar 13, 2026: 10,768 shares, avg. $50.08$539,220Aug 11, 2026
Plus 3 more entries from the last 12 months.
Plus one other filing such as a grant, option exercise or tax withholding. It is not a market purchase or sale.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.70/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+0.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.3%
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: adjusted.
+7.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year+7.9%
Dividend (yield on the price)0.0%
Profit margin 2021 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 16%
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far and about what analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+7.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+4.4%
Yearly sales growth analysts expect, extended to five years.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +4.8% a year for the price and +2.0% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (78 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Positive
Recent news coverage is more positive than average.
AI conclusion: The business benefits from robust North American demand driving revenue growth in cement, aggregates and building envelope, yet its main weakness remains oil-driven cost pressures that limit margin expansion.
Main risk: Further oil-driven increases in freight and raw material costs represent the biggest risk to the business by constraining margin expansion despite volume growth.
Amrize delivers revenue growth from robust demand in its North American cement, aggregates and building envelope businesses. Oil-driven increases in freight and raw material costs have nevertheless limited the expansion of margins so far this year. Will the timing of new price increases and the ASPIRE efficiency program allow profitability to catch up with volumes before further cost pressures mount?
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Building Materials · 257 stocks
Beats the industry median on 7/15 measures
A mixed picture versus its industry peers.
Valuation
Quality Score55 · Above median
Fair Value upside−17.7% · Below median
Profitability
Return on equity (12 months)9.7% · Above median
Return on assets4.9% · Above median
Net margin (12 months)10.2% · Top 25%
Operating margin (12 months)21.0% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)2.6% · Above median
Dividend yield (12 months)0.0% · Bottom 25%
Balance sheet
Debt / equity0.37× · Highest 25%
Valuation Multiplesvs Building Materials median · lower = cheaper
P/E (12 months)19.1× · Pricier than median
P/B1.78× · Pricier than median
P/S (12 months)1.93× · Pricier than median
Price / free cash flow (fiscal year)16.6× · Pricier than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Amrize Ltd Fair Value". https://www.fairvalue-calculator.com/stock/AMRZ
Frequently asked questions
Is Amrize Ltd (AMRZ) overvalued or undervalued?
As of Nov 5, 2026, our model estimates a fair value of $35.08 versus a price of $42.65, about 18% lower (overvalued).
What is the fair value of AMRZ?
Our model-based fair value for Amrize Ltd is $35.08 (as of Nov 5, 2026), built from audited fundamentals. The current price: $42.65.
What is the quality score of AMRZ?
Amrize Ltd has a Quality Score of 55/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Amrize Ltd (AMRZ)?
Our model-based price target is the fair value of $35.08 (as of Nov 5, 2026) from 23 valuation models. Cautious scenario $24.02, optimistic scenario $46.04. It is a calculation from audited fundamentals, not an analyst target.
What is the Amrize Ltd stock forecast for 2026?
Our models put fair value at $35.08, about 18% lower versus a price of $42.65 (overvalued). Cautious scenario $24.02, optimistic scenario $46.04. The calculation is refreshed regularly with new filings.
What is the revenue of Amrize Ltd (AMRZ)?
Amrize Ltd reported trailing-twelve-month revenue of about $12.3B (latest available figure, as of Nov 5, 2026).
What growth is priced into Amrize Ltd (AMRZ)?
For today's price to be fair in a discounted-cash-flow model, Amrize Ltd would have to grow free cash flow by +7.3 % per year for five years (discount rate 9.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 4 years revenue grew +9.8 % per year. As of Nov 5, 2026.
What discount rate (WACC) does the fair value of AMRZ use?
Our models discount Amrize Ltd at 9.2 %: a base by market capitalisation (large), country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Amrize Ltd that is +7.3 % per year a year over ten years, using the same discount rate (9.2 %) and the same formula as our fair value.
How much growth has Amrize Ltd (AMRZ) delivered so far?
Over the past 4 years revenue at Amrize Ltd grew +9.8 % a year. The price currently implies +7.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Amrize Ltd (AMRZ) growing?
The median revenue growth in the sector is +9.7 % a year. That is the yardstick for the growth priced into Amrize Ltd (+7.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Amrize Ltd (AMRZ)?
The free-cash-flow yield on the price is 6.01 %: that much free cash flow Amrize Ltd produces per unit of market value. When it exceeds the discount rate of our models (9.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Amrize Ltd (AMRZ)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Amrize Ltd it is $35.08 per share (as of Nov 5, 2026), against a price of $42.65. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Amrize Ltd stock overvalued or undervalued in 2026?
As of Nov 5, 2026, AMRZ trades above its calculated fair value: price $42.65, fair value $35.08, a gap of about −18% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AMRZ?
No. The price is what the market pays today ($42.65); the fair value is what the company's own numbers justify ($35.08). For Amrize Ltd the two are $7.57 per share apart. That gap is exactly why we show both numbers side by side.
How much is Amrize Ltd worth?
The market values Amrize Ltd at about $23.6B (market capitalisation, as of Nov 5, 2026). Per share that is $42.65; our models calculate a fair value of $35.08 per share.
What do the bullish and bearish scenarios say about AMRZ?
Our models span a range for Amrize Ltd: cautious scenario $24.02, base $35.08, optimistic $46.04 per share (as of Nov 5, 2026, price $42.65). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of AMRZ?
Amrize Ltd trades at a price-to-earnings ratio of 19.1 (as of Nov 5, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $35.08 is built from several models across several years. Other multiples: PEG 1.1, P/B 1.8, P/S 1.9, EV/EBITDA 9.1.
What is the PEG ratio of AMRZ?
The PEG ratio of Amrize Ltd is 1.10 (P/E divided by earnings growth, as of Nov 5, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Amrize Ltd (AMRZ)?
Balance-sheet figures for Amrize Ltd (as of Nov 5, 2026): return on equity 9.7%, debt of 0.37 per unit of equity. They feed the Quality Score of 55/100, which measures business quality independently of the share price.
How far is AMRZ from its 52-week high?
Amrize Ltd trades at $42.65, about 34% below its 52-week high of $65.06 and 18% above the low of $36.09 (as of Nov 5, 2026). Distance from the high says nothing about value: that is what the fair value of $35.08 is for.
Which stocks are comparable to Amrize Ltd?
From the same area (Basic Materials) we also value CRH plc, Holcim AG, Martin Marietta Materials, Inc, Vulcan Materials Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Amrize Ltd stock attractive at the current price?
The data as of Nov 5, 2026: price $42.65, calculated fair value $35.08 (−18%), Quality Score 55/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of AMRZ calculated?
We run Amrize Ltd through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $35.08, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.5% above its aggregate fair value. Amrize Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Amrize Ltd (AMRZ)?
The closing price on Nov 5, 2026 was $42.65. Our model-based fair value is $35.08, about 18% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Amrize Ltd right now?
Solid but not exceptional quality (55/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range ($24.02 to $46.04) leaves room in how you read the outcome.
Key figures of Amrize Ltd
How large is the market capitalisation of Amrize Ltd (AMRZ)?
The market capitalisation of Amrize Ltd is $23.6B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Amrize Ltd (AMRZ)?
The price-to-sales ratio of Amrize Ltd is 1.93 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Amrize Ltd (AMRZ)?
Earnings per share at Amrize Ltd are $2.23 (price ÷ EPS = P/E 19.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Amrize Ltd (AMRZ)?
The net margin of Amrize Ltd is 10.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Amrize Ltd (AMRZ)?
The return on equity (ROE) of Amrize Ltd is 9.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Amrize Ltd (AMRZ)?
On an EBIT basis the return on assets of Amrize Ltd is 8.4% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Amrize Ltd (AMRZ)?
The operating margin of Amrize Ltd is 21.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Amrize Ltd (AMRZ)?
Revenue at Amrize Ltd is growing +2.6% versus a year earlier (3y avg +3.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Amrize Ltd (AMRZ)?
Earnings per share at Amrize Ltd are growing +4.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Amrize Ltd (AMRZ) carry?
The net debt of Amrize Ltd is $4.0B (fiscal year 2025, ≈ 2.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Amrize Ltd in the live analysis
One click puts Amrize Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Some data
Nov 5, 2026